Statera Biopharma Inc STAB:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 05/03/24 EDT
0.0007UNCH (UNCH)
Volume
479
52 week range
0.00 - 0.04
Loading...
  • Open0.0007
  • Day High0.0007
  • Day Low0.0007
  • Prev Close0.0007
  • 52 Week High0.04
  • 52 Week High Date07/10/23
  • 52 Week Low0.00
  • 52 Week Low Date01/04/24

Key Stats

  • Market Cap22,469.997
  • Shares Out32.10M
  • 10 Day Average Volume5,005.75
  • Dividend-
  • Dividend Yield-
  • Beta0.94
  • YTD % Change16.67

KEY STATS

  • Open0.0007
  • Day High0.0007
  • Day Low0.0007
  • Prev Close0.0007
  • 52 Week High0.04
  • 52 Week High Date07/10/23
  • 52 Week Low0.00
  • 52 Week Low Date01/04/24
  • Market Cap22,469.997
  • Shares Out32.10M
  • 10 Day Average Volume5,005.75
  • Dividend-
  • Dividend Yield-
  • Beta0.94
  • YTD % Change16.67

RATIOS/PROFITABILITY

  • EPS (TTM)-1.72
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-0.01
  • EBITDA (TTM)-20.039M
  • ROE (TTM)-287.51%
  • Revenue (TTM)3.688M
  • Gross Margin (TTM)70.27%
  • Net Margin (TTM)-2,490.94%
  • Debt To Equity (MRQ)-62.46%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Statera Biopharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapies autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. It has platform of toll-like receptor (TLR) agonists with TLR4 and TLR9 antagonists, and the TLR5 agonists, Entolimod and GP532. The Company is developing therapies designed to directly...
Michael Handley
Chairman of the Board, President, Chief Executive Officer
Christopher Zosh
Interim Chief Financial Officer, Executive Vice President - Finance, Interim Chief Accounting Officer
Robert Buckheit Jr.
Chief Technology Officer
Address
2537 Research Boulevard, Suite 201
Fort Collins, CO
80526
United States

Top Peers

SYMBOLLASTCHG%CHG
BLPH
Bellerophon Therapeutics Inc
0.0625UNCHUNCH
TCON
TRACON Pharmaceuticals Inc
1.86+0.05+2.76%
ATHXQ
Athersys Inc
0.0043+0.0002+4.878%
TNXP
Tonix Pharmaceuticals Holding Corp
0.1835+0.0124+7.2472%
SQZB
SQZ Biotechnologies Co
0.0499UNCHUNCH